RecallRadar

FDA Device recall Z-2328-2015

Philips HeartStart XL+ Defibrillator/Monitor Product Usage: The HeartStart XL+ is intended for use in a hospital setting by qualified medic…

On 2015-08-12 the FDA classified a Class II recall of Philips HeartStart XL+ Defibrillator/Monitor Product Usage: The HeartStart XL+ is intended for use in a hospital setting by qualified medic… by Philips Electronics North America, citing multiple software and hardware issues with device that can affect its function.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2328-2015
ClassificationClass II
Statusterminated
Initiated2015-06-05
Published2015-08-12
Last updated2026-09-13 11:53 UTC
CompanyPhilips Electronics North America
DistributionUS

Product

Philips HeartStart XL+ Defibrillator/Monitor Product Usage: The HeartStart XL+ is intended for use in a hospital setting by qualified medical personnel trained in the operation of the device and qualified by training in basic life support, advanced life support or defibrillation. When operating as a semi-automatic external defibrillator in AED Mode, the HeartStart XL+ is suitable for use by medical personnel trained in basic life support that includes the use of an AED. When operating in Monitor, Manual Defibrillation or Pacing modes, the HeartStart XL+ is suitable for use by healthcare professionals trained in advance life support.

Reason

Multiple software and hardware issues with device that can affect its function.

Identifiers

code_infoSerial Numbers in the following ranges: USO1100100 to USD1101095, US11201096 to USD1203968, US11303969 to USD1309471, US11409472 to US61414022

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2328-2015%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.